首页 | 本学科首页   官方微博 | 高级检索  
     


A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer
Authors:Stacy Moulder  Navneet Dhillon  Chaan Ng  David Hong  Jennifer Wheler  Aung Naing  Susan Tse  Amy La Paglia  Robert Dorr  Evan Hersh  Michelle Boytim  Razelle Kurzrock
Affiliation:1. Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Unit 1354, 1155 Pressler Street, P.O. Box 301438, Houston, TX, 77030, USA
2. Investigational Cancer Therapeutics (Phase I Program), University of Texas M. D. Anderson Cancer Center, Houston, USA
3. Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, Houston, USA
4. ABC Laboratories, Columbia, USA
5. AmpliMed Corporation, Tucson, AZ, USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号